Invesaro

Stocks CDLX DCF valuation

DCF valuation

What is Cardlytics, Inc. worth?

With the base-case assumptions below, a discounted cash flow model on Cardlytics, Inc.'s reported free cash flow gives -$0.00 per share. The share price was $3.30 on September 25, 2026, 6,011,145% below that value.

Inputs from the filings

Free cash flow, fiscal 2025
$8.8M
Average free cash flow, last 5 years
-$19.8M
Cash
$28M
balance sheet of June 30, 2026
Debt
$184.4M
balance sheet of June 30, 2026
Diluted shares, fiscal 2025
53,114,000
Revenue growth per year, last 5 years
4.5%

Three sets of assumptions

CaseGrowth yrs 1-5Growth yrs 6-10After year 10Discount rateValue per shareValue vs price
Bear-0.5%0.5%2.0%10.0%-$1.12-134%
Base4.5%3.5%2.5%9.0%-$0.00-100%
Bull9.5%6.5%3.0%8.0%$2.19-34%

Sensitivity: base case value per share

Discount rate down the side, growth after year 10 across the top. Everything else as in the base case.

1.5%2.0%2.5%3.0%3.5%
7.0%$0.80$1.04$1.34$1.71$2.19
8.0%$0.20$0.36$0.55$0.77$1.04
9.0%-$0.23-$0.12-$0.00$0.14$0.32
10.0%-$0.56-$0.49-$0.40-$0.30-$0.19
11.0%-$0.83-$0.77-$0.71-$0.64-$0.56

Where the presets come from

Base: years 1 to 5 grow at Cardlytics, Inc.'s revenue growth rate over the last 5 fiscal years (4.5% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.

Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.

Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.

This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.

Adjust the assumptions

Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.

Adjust the assumptions

Cardlytics, Inc. company page